Participants 38 75 6
patients with advanced gastric cancer
Participants 289 363 6
patients with non-resectable gastric and gastro-oesophageal adenocarcinoma
Participants 365 529 7
Three hundred and sixty-nine patients with histological proof of adenocarcinoma, who had received no more than a single regimen of 5-fluorouracil-based chemotherapy
